<DOC>
	<DOC>NCT00318604</DOC>
	<brief_summary>This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.</brief_summary>
	<brief_title>Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Head and neck cancers Esophageal cancer Undergoing anticancer treatments No distant metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>plasma circulating DNA</keyword>
	<keyword>hean and neck cancers</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>localized head and neck cancers</keyword>
	<keyword>localized esophageal cancer</keyword>
</DOC>